Northern Trust
CLBT icon

Northern Trust’s Cellebrite CLBT Stock Holding History

Northern Trust’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.39M Buy
300,513
+101,177
+51% +$1.34M ﹤0.01% 2690
2026
Q1 		$2.75M Sell
199,336
-225,952
-53% -$3.41M ﹤0.01% 2802
2025
Q4 		$7.67M Sell
425,288
-29,718
-7% -$534K ﹤0.01% 2219
2025
Q3 		$8.43M Buy
455,006
+243,635
+115% +$3.83M ﹤0.01% 2211
2025
Q2 		$3.38M Sell
211,371
-63,044
-23% -$1.12M ﹤0.01% 2705
2025
Q1 		$5.33M Buy
274,415
+62,421
+29% +$1.31M ﹤0.01% 2379
2024
Q4 		$4.67M Buy
211,994
+112,731
+114% +$2.17M ﹤0.01% 2544
2024
Q3 		$1.67M Buy
99,263
+88,570
+828% +$1.31M ﹤0.01% 3107
2024
Q2 		$128K Buy
+10,693
New +$119K ﹤0.01% 3986
2023
Q4 		– Sell
-13,802
Closed -$106K – 4487
2023
Q3 		$106K Buy
13,802
+2,639
+24% +$19.8K ﹤0.01% 3998
2023
Q2 		$80.4K Hold
11,163
– – ﹤0.01% 4093
2023
Q1 		$68K Hold
11,163
– – ﹤0.01% 4184
2022
Q4 		$48.7K Buy
+11,163
New +$49.9K ﹤0.01% 4292

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Northern Trust's CLBT Position: Q2 2026 in Review

Northern Trust increased its Cellebrite (CLBT) stake by 51% in Q2 2026, buying an estimated $1.34M and bringing the position to 300,513 shares worth $4.39M. The position accounts for ﹤0.01% of the portfolio, ranked #2690.

Northern Trust first reported a position in CLBT in Q4 2022 and has held it in 13 quarters since. The position peaked at $8.43M in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Northern Trust held 300,513 shares of Cellebrite worth $4.39M as of Q2 2026.
  • Northern Trust bought 101,177 Cellebrite shares in Q2 2026, an estimated $1.34M.
  • Cellebrite made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2690 holding.
  • Northern Trust first reported a position in Cellebrite in Q4 2022 and has held it in 13 quarters since.
  • Northern Trust's Cellebrite position peaked at $8.43M in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.